Drew Moghanaki: IMRT with MR-linac and VMAT for lung SABR
Drew Moghanaki shared a post on X about a paper by Jong Min Park et al. published in Radiation Oncology.
“Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR”
Authors: Jong Min Park, Hong-Gyun Wu, Hak Jae Kim, Chang Heon Choi and Jung-in Kim.
“Here are the results of a dosimetric study published in 2019 demonstrating how MRIdian-based lung SBRT can reduce incidental doses delivered to the heart (green) and esophagus (orange).”
Source: Drew Moghanaki/X
More posts featuring Drew Moghanaki.
Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.
He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023